Payday lenders took in $2.4 billion in fees from cash-strapped consumers in a single year, a report from the Center for ...

Growth across the Manufacturing and RMS segments is likely to have contributed to Charles River's fourth-quarter revenues.

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, ...

In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...

Upslope Capital Management, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. Q4 was the most challenging quarter for ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Morgan Stanley analyst Tejas Savant lowered the firm’s price target on Charles River (CRL) to $184 from $220 and keeps an Equal Weight rating ...

Chiefs-Bills national anthem has Chris Jones in tears as Super Bowl demand made As The H-1B Visa Debate Tears MAGA Apart, ...

Crossmark Global Holdings Inc. lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free ...

Atomi Financial Group Inc. reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by ...

Fintel reports that on January 22, 2025, William Blair downgraded their outlook for Charles River Laboratories International (NYSE:CRL) from Outperform to Market Perform. Analyst Price Forecast ...

T-cell immunotherapy company Atara Biotherapeutics closed 8% lower on Tuesday, having lost 41% of its stock market value on Friday.